Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease
Crossref DOI link: https://doi.org/10.1007/s00467-017-3579-6
Published Online: 2017-03-22
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Webb, Nicholas J. A.
Lerner, Gary
Warady, Bradley A.
Dell, Katherine M.
Greenbaum, Larry A.
Ariceta, Gema
Hoppe, Bernd
Linde, Peter
Lee, Ho-Jin
Eldred, Ann
Dufek, Matthew B.
Funding for this research was provided by:
AbbVie
License valid from 2017-03-22